Phenotypic Drug Discovery – The Move from High Content to High Impact Screening



October 19, 2016

  • Share
  • Beverley Isherwood, Innovative Medicines, AstraZeneca, UK, speaking at High Content & Phenotypic Screening 2016.

    Drug Discovery

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.